While cognitive symptoms remain the primary basis for clinical differentiation between LBD and PD [9], other proteins such as Aβ, Tau, and TAR DNA-binding protein-43 (TDP-43) contribute to the unique pathological profile of LBD and may enhance diagnostic accuracy. This evidence concerns the gene MAPT and Parkinson disease.